Barriers and Challenges to Global Clinical Cancer Research
Open Access
- 9 December 2013
- journal article
- global health-and-cancer
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 19 (1), 61-67
- https://doi.org/10.1634/theoncologist.2013-0290
Abstract
Background.: There are concerns about growing barriers to cancer research. We explored the characteristics of and barriers to global clinical cancer research. Methods.: The American Society of Clinical Oncology International Affairs Committee invited 300 selected oncologists with research experience from 25 countries to complete a Web-based survey. Fisher's exact test was used to compare answers between participants from high-income countries (HICs) and low- and middle-income countries (LMICs). Barriers to clinical cancer research were ranked from 1 (most important) to 8 (least important). Mann-Whitney's nonparametric test was used to compare the ranks describing the importance of investigated obstacles. Results.: Eighty oncologists responded, 41 from HICs and 39 from LMICs. Most responders were medical oncologists (62%) at academic hospitals (90%). Researchers from HICs were more involved with academic and industry-driven research than were researchers from LMICs. Significantly higher proportions of those who considered their ability to conduct academic research and industry-driven research over the past 5 years more difficult were from HICs (73% vs. 27% and 70% vs. 30%, respectively). Concerning academic clinical cancer research, a lack of funding was ranked the most important (score: 3.16) barrier, without significant differences observed between HICs and LMICs. Lack of time or competing priorities and procedures from competent authorities were the second most important barriers to conducting academic clinical research in HICs and LMICs, respectively. Conclusion.: Lack of funding, lack of time and competing priorities, and procedures from competent authorities might be the main global barriers to academic clinical cancer research.Keywords
Funding Information
- American Society of Clinical Oncology International Affairs Committee
This publication has 23 references indexed in Scilit:
- Removing barriers to participation in clinical trials, a conceptual framework and retrospective chart review studyTrials, 2012
- Global core competencies for clinical trialsThe Lancet, 2012
- Improving Cancer Outcomes Through International Collaboration in Academic Cancer Treatment TrialsJournal of Clinical Oncology, 2009
- Global drug development in cancer: a cross-sectional study of clinical trial registriesAnnals Of Oncology, 2009
- Ethical and Scientific Implications of the Globalization of Clinical ResearchNew England Journal of Medicine, 2009
- Evolution of the Randomized Controlled Trial in Oncology Over Three DecadesJournal of Clinical Oncology, 2008
- The impact of the ‘Clinical Trials’ directive on the cost and conduct of non-commercial cancer trials in the UKEuropean Journal Of Cancer, 2007
- Why don’t cancer patients enter clinical trials? A reviewEuropean Journal Of Cancer, 2006
- A Survey of Public Funding of Cancer Research in the European UnionPLoS Medicine, 2006
- Pattern of care and impact of participation in clinical studies on the outcome in ovarian cancerInternational Journal of Gynecologic Cancer, 2005